IRVINE, Calif. & BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, today reported the results of its first Phase 3 registration trial (Rocket 1) for RhopressaTM, a novel once-daily, triple-action eye drop being tested for its ability to
TARRYTOWN, N.Y.–(BUSINESS WIRE)–Prestige Brands Holdings, Inc. (NYSE:PBH) announced today that Matthew M. Mannelly, President and Chief Executive Officer and member of the Board of Directors, will retire effective June 1, 2015. Following his retirement, the Board of Directors has appointed Ron Lombardi, Chief Financial Officer, to succeed Mr. Mannelly as President and Chief Executive Officer. The company has commenced a search for a new Chief Financial Officer. “Ron and Matt have worked toget
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/kjmvvr/global_and) has announced the addition of the “Global and Chinese Visual chart monitor Industry, 2010-2020 Market Research Report” report to their offering…
MURRIETA, Calif.–(BUSINESS WIRE)–II-VI Optical Systems (II-VI OS) will present at the SPIE-DSS show in Baltimore Maryland, April 20-23, 2015, Booth #725.
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Eleven Biotherapeutics to Report First Quarter 2015 Financial Results on April 30, 2015
INDIANAPOLIS–(BUSINESS WIRE)–Anthem, Inc., offers six tips for maintaining healthy eyes in recognition of Women’s Eye Health and Safety Month.
LONDON–(BUSINESS WIRE)–Technavio has published a new report on the smart glasses market for augmented reality (AR), which is expected to grow at a CAGR 194.2% from 2015-2019.
SUNNYVALE, Calif.–(BUSINESS WIRE)–Phase 3 trial data showed that IBI-10090 is highly effective in treating inflammation post cataract surgery.
PLEASANTON, Calif.–(BUSINESS WIRE)–Clarity Medical Systems, Inc., a developer and marketer of ophthalmic diagnostic imaging technologies, is pleased to announce that their product, RetCam, will be utilized to image premature infant eyes in a study to evaluate a potential new method for treating Retinopathy of Prematurity (ROP) using Lucentis™ (ranibizumab). “The use of RetCam in a study of this medical significance demonstrates the growing worldwide acceptance of RetCam for pediatric retinal
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida VP of Research to discuss company’s protein and antibody sustained delivery system at upcoming Ocular diseases and drug conference
LAKE FOREST, Calif.–(BUSINESS WIRE)–ReVision Optics®, Inc. (RVO), a leader in implantable inlay technology to treat presbyopia, reported a high level of satisfaction from a group of 58 patients treated for presbyopia at the Ultralase Clinics in the …
SAN DIEGO–(BUSINESS WIRE)–Free app is now available, making Android smartphones more accessible for postpaid and no-contract Sprint customers
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida announces positive outcome to European Decentralized procedure for approval for ILUVIEN for treatment of chronic diabetic macular edema
SANTA CLARA, Calif.–(BUSINESS WIRE)–OptiMedica begins shipping the Catalys Precision Laser System for cataract surgery in the U.S. First U.S. patients have been treated at Mann Eye Institute in Houston.